Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
By Andrew Silver SHANGHAI (Reuters) – Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market…
By Andrew Silver SHANGHAI (Reuters) – Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market…
By Sumeet Chatterjee and Scott Murdoch HONG KONG/SYDNEY (Reuters) – Billionaire Richard Li has revived plans to list pan-Asian insurer…
By Andrea Shalal WASHINGTON (Reuters) – Stand with Crypto, an advocacy organization for voters who own cryptocurrencies, saw its membership…
(Reuters) – The S&P 500 and the Dow futures were little changed on Thursday as investors awaited fresh data to…
(Reuters) -TXSE Group, backed by BlackRock and Citadel Securities, plans to launch the Texas Stock Exchange based in Dallas, a…
By Timothy Gardner WASHINGTON (Reuters) – The United States could revive some of its recently retired nuclear power plants to…
(Reuters) -Activist investor Elliott Management has rebuilt a stake worth more than $2 billion in Japanese technology investor SoftBank Group…
(Reuters) – Shares of Nvidia rallied to record highs on Wednesday, with the AI chipmaker’s stock market valuation on the…
By Dietrich Knauth NEW YORK (Reuters) – A Pennsylvania judge on Tuesday slashed a $2.25 billion U.S. verdict against Bayer…
(Reuters) – Short video app TikTok has taken measures to stop a cyberattack targeting several brand and celebrity accounts, including…